- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03808233
Reliability and Validity of the ACTIVE-mini for Quantifying Movement in Infants With Spinal Muscular Atrophy
January 14, 2019 updated by: University of Texas Southwestern Medical Center
The purpose of this study is to investigate the measurement properties of the Ability Captured Through Interactive Video Evaluation-mini (ACTIVE-mini) for quantifying movement in infants with Spinal Muscular Atrophy (SMA).
Specifically, I will investigate within-day and between-day test-retest reliability and calculate the minimal detectable change of the ACTIVE-mini.
Additionally, I will determine the concurrent validity of the ACTIVE-mini with The Children's Hospital of Philadelphia Infant Test for Neuromuscular Disease (CHOP INTEND) and the construct validity of the ACTIVE-mini in infants with SMA using a known group methodology.
Study Overview
Detailed Description
This study was a cross-sectional, repeated measure design, investigating the test-retest within- and between-day reliability and the convergent construct validity and the known-groups method construct validity of the ACTIVE-mini.
The group variable included two levels (non-rolling infants with SMA and function matched non-rolling typically developing infants).
The dependent variables included a predicted CHOP INTEND score determined by data captured by the ACTIVE-mini and the CHOP INTEND extremity score.
The dependent variables were collected at two time points over two days at a minimum of 24 hours and no more than 30 days between collections.
Variables were collected in a standard order of assessment.
All participants underwent all assessments as set out in the procedures.
Based on results from pilot data, the conclusion was made that the ACTIVE-mini could quantify infant movement parameters well enough to warrant further investigation.
These data were important in establishing the feasibility of the specific aims of this research, because they provide initial validation of the ability of ACTIVE-mini to quantify basic infant movement parameters
Study Type
Observational
Enrollment (Actual)
25
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- ADULT
- OLDER_ADULT
- CHILD
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
SMA
Description
Inclusion Criteria:
-
Participants will be included in this study if they:
- are non-rolling at time of enrollment
- age birth to 25 months
- have no concomitant system pathology that would limit clinical evaluation.
These inclusion criteria are set for both affected babies and healthy controls.
Exclusion Criteria:
Participants will be excluded from this study if they:
- demonstrate evidence of renal dysfunction, central nervous system damage, neuro-degenerative or neuromuscular disease other than SMA type I or II;
- require mechanical ventilation of any type > 16 hours per day.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Spinal Muscular Atrophy Type 1
Non rolling infants or children with SMA
|
the ACTIVE-mini, is a non-invasive method of recording movement in an infant using a KINECT camera system.
This camera is positioned over a resting infant and measures natural movement over a two minute time period.
|
Non Rolling Function matched control
Non rolling typically developing infant
|
the ACTIVE-mini, is a non-invasive method of recording movement in an infant using a KINECT camera system.
This camera is positioned over a resting infant and measures natural movement over a two minute time period.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
ACTIVE mini
Time Frame: 2 minutes
|
the ACTIVE-mini, is a physiological parameter non-invasive method of recording movement in an infant using a KINECT camera system.
This camera is positioned over a resting infant and measures natural movement over a two minute time period.
|
2 minutes
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
November 5, 2016
Primary Completion (ACTUAL)
June 1, 2018
Study Completion (ACTUAL)
August 31, 2018
Study Registration Dates
First Submitted
June 29, 2018
First Submitted That Met QC Criteria
January 14, 2019
First Posted (ACTUAL)
January 17, 2019
Study Record Updates
Last Update Posted (ACTUAL)
January 17, 2019
Last Update Submitted That Met QC Criteria
January 14, 2019
Last Verified
January 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU 052016-109
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Muscular Atrophy
-
Marco CapogrossoRoche-GenentechRecruitingSpinal Muscular Atrophy Type 3 | Spinal Muscular Atrophy Type 4United States
-
Institut de Myologie, FranceInstitut RocheCompletedType 2 Spinal Muscular Atrophy | Type 3 Spinal Muscular AtrophyBelgium, France, Germany
-
Marco CapogrossoRoche-GenentechNot yet recruitingSpinal Muscular Atrophy | Spinal Muscular Atrophy Type 3 | SMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy 4United States
-
Novartis Gene TherapiesActive, not recruitingSMA | Spinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type I | Spinal Muscular Atrophy Type IIIUnited States, Belgium, France, Japan, United Kingdom, Italy, Taiwan, Australia, Canada
-
Hoffmann-La RocheRecruitingSpinal Muscular Atrophy (SMA)Belgium, United States, Croatia, Japan, Netherlands, Spain, Canada, Poland, United Kingdom, Portugal, Italy, Australia
-
Northwell HealthCompletedAdult Spinal Muscular AtrophyUnited States
-
Hugh McMillanFamilies of Spinal Muscular Atrophy; Gwendolyn Strong FoundationTerminatedSpinal Muscular Atrophy (SMA)Canada
-
AveXis, Inc.United BioSource, LLCRecruitingSpinal Muscular Atrophy (SMA)Japan, United States, Korea, Republic of, Israel, Greece, Ireland, Portugal, Russian Federation, Taiwan
-
Hoffmann-La RocheAssociation Française contre les Myopathies (AFM), ParisCompletedSpinal Muscular Atrophy Type II | Spinal Muscular Atrophy Type III Non AmbulantGermany, Italy, France, Belgium, Poland, Netherlands, United Kingdom
-
Istanbul Medipol University HospitalIstanbul UniversityRecruitingNeuromuscular Diseases | Spinal Muscular Atrophy Type 3Turkey
Clinical Trials on ACTIVE mini
-
NYU Langone HealthNational Multiple Sclerosis SocietyCompleted
-
Centre for Addiction and Mental HealthUniversity Health Network, TorontoCompletedMajor Depressive DisorderCanada
-
Florida State UniversityNational Institute of Nursing Research (NINR)CompletedOsteo Arthritis KneeUnited States
-
NYU Langone HealthCompleted
-
Stephane ARMANDLa Tour Hospital; School of Health Sciences GenevaRecruitingChronic Low Back PainSwitzerland
-
Mahidol UniversityNot yet recruitingSafety Issues | Surgery-Complications | Nephrolithiasis Staghorn CalculusThailand
-
Albert Einstein College of MedicineMJHS Institute for Innovation in Palliative CareRecruitingDementia | Alzheimer DiseaseUnited States
-
Washington University School of MedicineBoston Scientific CorporationCompletedNSCLC | Non Small Cell Lung CancerUnited States
-
PfizerCompletedHealthy ParticipantsBelgium
-
Shiraz University of Medical SciencesCompletedCleft Palate | Maxillary Hypoplasia | Maxillary RetrognathismIran, Islamic Republic of